ArticleMikrochimica acta2025
One-pot green synthesis of protein-modified ternary quantum dots.
Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
In order to improve the stability, biocompatibility, and emissions of aqueous I-III-VI ternary quantum dots (QDs we report for the first time the one-pot two-step green synthesis method with proteins serving as modifier. As a proof of concept, bovine serum albumin (BSA) and lysozyme (Lys) modified CuInS@ZnS ternary core-shell QDs were synthesized respectively. The results indicate that proteins have no influence on the morphology, composition, and lattice of quantum dots. However, they can significantly increase the fluorescence intensity of quantum dots (by 1.5 times) and the fluorescence lifetime (by 3.5 times). In addition, protein modification sharply enhanced the stability of quantum dots in various media. Moreover, for the first time, the binding interaction between proteins and quantum dots was directly verified using the fluorescence quenching technique. Thereafter, the bacterial target and antibacterial function imparted to QDs by lysozyme were demonstrated. Finally, we verified the application potential of CIS/ZnS@Lys in different medical scenarios, which performed well in wound disinfection, imaging bacterial adhesion in medical catheters, and killing the adhered bacteria.
Indexed as
Identifiers
40522544What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.